Temporary Change in Status for the Stimulants Drug Class Effective April 22, 2020
HHSC has been informed of a drug shortage for Methylphenidate ER in the Stimulants drug class. FirstCare temporarily removed the non-preferred status from the brand formulations of the NDCs below on April 22, 2020. These changes will allow providers to prescribe for these drugs without requiring a PDL prior authorization and allow continued access to necessary medication for clients. This is a temporary change until the preferred products are sufficiently available in the market. FirstCare will announce any further PDL status changes of these NDCs.
* Required field
ATTENTION: By clicking “Continue”, you will be leaving the FirstCare Medicare Dual SNP (HMO SNP) site pages. If you wish to remain on these pages, simply click “Cancel” or close this box.